LIFEPharma, a USFDA approved pharmaceutical manufacturer and a part of VPS Health, has announced the establishment of a dedicated spin off biotech focused on end to end development of cell and gene therapies.
Saudi Arabia's Ministry of Health (MoH), the Ministry of Defense (MoD) and the National Center for Privatization & PPP (NCP) have launched the Expression of Interest (EOI) and Request for Qualification (RFQ) phase for a major renal care project.
The next edition of WHX Tech will take place from January 27–29, 2027 at the Dubai World Trade Centre (DWTC). The event will run alongside World Health Expo (WHX), the flagship global healthcare event.
PureHealth Holding, the largest healthcare group in the Middle East, reported a revenue increase of 10% year-on-year in the first quarter to AED7.3 billion ($1.99, driven by strong growth in PureHealth’s international Care (healthcare) portfolio and the Cover (insurance) vertical.
The Emirates Drug Establishment (EDE) has officially granted approval for EURneffy, a novel epinephrine-based treatment available in 1 mg and 2 mg strengths, making the UAE the first country in the region to authorise this innovative therapy.
Novo Nordisk has announced positive topline results from Pioneer Teens, a phase 3a trial evaluating oral semaglutide for type 2 diabetes in children and adolescents aged 10–17 years.
NMC Healthcare Group (NMC), a leading integrated private healthcare provider in the United Arab Emirates, has opened a new clinic in Al Riyadh City, Abu Dhabi.
Emirates Water and Electricity Company (Ewec) has announced the extension of its clean energy partnership with Mediclinic, the first healthcare institution in Abu Dhabi to decarbonise their operations. The deal ensures all Mediclinic’s hospitals will be powered by clean electricity, verified using CECs issued by Abu Dhabi.
The Emirates Drug Establishment (EDE) has announced the country’s first fully AI-discovered and developed drug candidate by a research team at Insilico Medicine.
M42, a global health leader powered by AI, technology and genomics, and its world leading renal care business, Diaverum, on Thursday announced the completion of a strategic acquisition of four clinics in the state of São Paulo, Brazil, from the Lund Group.
